WHO's new guidelines for antiretroviral treatment

Bassett, Mary T.; Brudney, Karen

doi:10.1016/s0140-6736(13)62538-6

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, concerns have been raised regarding the range of social and clinical complexities associated with TasP. For example, if the expectations now ascribed to TasP are to be achieved, the many persistent barriers that exist to linking and retaining people in HIV care and treatment will need to be overcome [19,20]. Others have questioned the wisdom of increasing the number of people using ART without fully understanding potential long term adverse effects [21], the risk of a focus on TasP reducing financial support for other HIV prevention strategies [22][23][24], and the complex ethical issues associated with advocating individual treatment to attain a public benefit of reduced community viral load [25].…”

Section: Introductionmentioning

confidence: 99%

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy

et al. 2014

View full text Add to dashboard Cite

The use of antiretroviral therapy to prevent HIV transmission is now advocated in many settings, yet little research has documented the views of people with HIV. Semi-structured interviews were conducted in Australia between 2012 and 2014 with 27 HIV-positive people not using treatment at the time of interview. Thematic analysis of views on treatment-as-prevention found that while many participants recognised potential prevention benefits, only a minority was in support of initiating treatment solely to achieve those benefits. A range of uncertain or critical views were expressed regarding who would benefit, risk reduction, and changing treatment norms. Participants resisted responsibility narratives that implied treatment should be used for the public good, in favour of making considered decisions about their preferred approach to managing HIV. Engaging communities in dialogue and debate regarding the risks and benefits of treatment will be critical if this new prevention strategy is to engender public trust.

show abstract

Section: Introductionmentioning

confidence: 99%

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy

et al. 2014

View full text Add to dashboard Cite

show abstract

“…29 The World Health Organization is the purveyor of guidelines for poor countries that lack capacity to develop them. Yet the challenge of delivery remains.…”

Section: Holding the Line For Promoting Health Systemsmentioning

confidence: 99%